{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 6, "transaction_limit": 160, "filters": {"q": "", "ticker": "INMB", "sector": "", "industry": "", "side": "", "start": "2026-06-18", "end": "2026-08-02"}, "summary": {"total": 6, "acquisition_count": 3, "disposal_count": 3, "acquisition_value": 43436.4, "acquisition_value_label": "$43.4K", "disposal_value": 3878.25, "disposal_value_label": "$3.9K", "net_value": 39558.15, "net_value_label": "$39.6K", "flow_tone": "positive", "largest_value_label": "$20.7K", "top_sector": "Healthcare", "window_label": "18 Jun 2026 to 02 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 6, "value": "47314.6500", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$47.3K"}], "days": [{"transaction_date": "2026-07-02", "acquisitions": 3, "disposals": 3, "total": 6, "bar_width": 100.0}], "side_mix": {"acquisitions": 3, "disposals": 3, "acquisition_share": 50.0, "disposal_share": 50.0}}, "company_flows": [{"symbol": "INMB", "name": "INmune Bio Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-02", "acquisitions": 3, "disposals": 3, "acquired_value": 43436.4, "acquired_value_label": "$43.4K", "disposed_value": 3878.25, "disposed_value_label": "$3.9K", "net_value": 39558.15, "net_value_label": "$39.6K", "acquisition_share": 50.0, "disposal_share": 50.0, "detail_url": "https://sharemaestro.com/insider-activity/company/inmb/", "research_links": {"chart": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/", "report": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/report/", "factor": "/factors/ticker/cdd69a93-4466-4dd1-84c5-99c098804d49/"}}], "company_overview": [{"symbol": "INMB", "name": "INmune Bio Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-02", "filings": 6, "acquisitions": 3, "disposals": 3, "acquired_value": 43436.4, "acquired_value_label": "$43.4K", "disposed_value": 3878.25, "disposed_value_label": "$3.9K", "net_value": 39558.15, "net_value_label": "$39.6K", "acquisition_share": 50.0, "disposal_share": 50.0, "tone": "Mixed flow", "tone_class": "neutral", "detail_url": "https://sharemaestro.com/insider-activity/company/inmb/", "research_links": {"chart": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/", "report": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/report/", "factor": "/factors/ticker/cdd69a93-4466-4dd1-84c5-99c098804d49/"}}], "transactions": [{"symbol": "INMB", "name": "INmune Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "JUDA, SCOTT", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 14801.0, "share_price": 1.4, "transaction_value": 20721.4, "fetched_at": "2026-07-23T10:51:55.074534+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/inmb/", "research_links": {"chart": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/", "report": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/report/", "factor": "/factors/ticker/cdd69a93-4466-4dd1-84c5-99c098804d49/"}}, {"symbol": "INMB", "name": "INmune Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "MOSS, DAVID J", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 9014.0, "share_price": 1.4, "transaction_value": 12619.6, "fetched_at": "2026-07-23T10:51:55.080631+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/inmb/", "research_links": {"chart": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/", "report": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/report/", "factor": "/factors/ticker/cdd69a93-4466-4dd1-84c5-99c098804d49/"}}, {"symbol": "INMB", "name": "INmune Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "LOWDELL, MARK WILLIAM", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 7211.0, "share_price": 1.4, "transaction_value": 10095.4, "fetched_at": "2026-07-23T10:51:55.086072+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/inmb/", "research_links": {"chart": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/", "report": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/report/", "factor": "/factors/ticker/cdd69a93-4466-4dd1-84c5-99c098804d49/"}}, {"symbol": "INMB", "name": "INmune Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "JUDA, SCOTT", "executive_title": "Director", "security_type": "Common Stock Purchase Warrant", "side_code": "D", "side": "Disposal", "shares": 14801.0, "share_price": 0.125, "transaction_value": 1850.125, "fetched_at": "2026-07-23T10:51:55.083249+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/inmb/", "research_links": {"chart": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/", "report": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/report/", "factor": "/factors/ticker/cdd69a93-4466-4dd1-84c5-99c098804d49/"}}, {"symbol": "INMB", "name": "INmune Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "MOSS, DAVID J", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock Purchase Warrant", "side_code": "D", "side": "Disposal", "shares": 9014.0, "share_price": 0.125, "transaction_value": 1126.75, "fetched_at": "2026-07-23T10:51:55.088123+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/inmb/", "research_links": {"chart": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/", "report": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/report/", "factor": "/factors/ticker/cdd69a93-4466-4dd1-84c5-99c098804d49/"}}, {"symbol": "INMB", "name": "INmune Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "LOWDELL, MARK WILLIAM", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock Purchase Warrant", "side_code": "D", "side": "Disposal", "shares": 7211.0, "share_price": 0.125, "transaction_value": 901.375, "fetched_at": "2026-07-23T10:51:55.078321+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/inmb/", "research_links": {"chart": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/", "report": "/terminal/cdd69a93-4466-4dd1-84c5-99c098804d49/report/", "factor": "/factors/ticker/cdd69a93-4466-4dd1-84c5-99c098804d49/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}